Manatuck Hill Partners, LLC Cytosorbents Corp Transaction History

Manatuck Hill Partners, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$6.28 - $10.59 $785,000 - $1.32 Million	-125,000 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$3.77 - $7.73 $471,250 - $966,250	125,000 New	125,000 $966,000
Q1 2019 May 15, 2019	SELL	$6.82 - $8.56 $1.32 Million - $1.66 Million	-194,100 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$7.05 - $12.64 $769,860 - $1.38 Million	-109,200 Reduced 36.0%	194,100 $1.57 Million
Q3 2018 Nov 14, 2018	BUY	$10.95 - $14.8 $493,844 - $667,480	45,100 Added 17.47%	303,300 $3.91 Million
Q2 2018 Aug 14, 2018	BUY	$6.9 - $12.35 $82,800 - $148,200	12,000 Added 4.87%	258,200 $2.94 Million
Q1 2018 May 15, 2018	BUY	$6.55 - $8.2 $475,530 - $595,320	72,600 Added 41.82%	246,200 $1.74 Million
Q4 2017 Feb 14, 2018	BUY	$5.9 - $7.05 $139,240 - $166,380	23,600 Added 15.73%	173,600 $1.13 Million
Q3 2017 Nov 14, 2017	BUY	$4.5 - $6.2 $675,000 - $930,000	150,000	150,000 $930,000

16.4M

15.4K

Ticker CTSO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 43,577,400
Market Cap $52.7M
Description
Cytosorbents Corporation engages in the research, development, and commercialization of medical devices with its blood purification technology platform incorporating a proprietary adsorbent and porous polymer technology. Its flagship product is CytoSorb, an extracorporeal cytokine filter for adjunctive therapy in the treatment of sepsis, adjunct...

Get notified when there are updates to the investment portfolio of Manatuck Hill Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Manatuck Hill Partners, LLC with notifications on news.